catalyst

A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2019-09-11 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of — primary completion
Type
Trial Readout
Date
2019-09-11
Date type
ACTUAL
Phase
Phase 2
This event happened.
relationships
The graph out of here
trial
A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia
trial